This week in cardiology from heartwire
View all posts »#108: Statin decisions in new-onset diabetes; possible rivaroxaban antidote; elective LVAD in advanced HF?; twice-daily aspirin: better platelet inhibition in diabetics; acute-HF early-warning system implant surprises
Sep 23, 2011 14:55 EDT-
2Comments
-
Read later
For the week ending September 23, 2011 we discuss the following top cardiology news from heartwire:
- Should you start a statin in a newly diagnosed diabetic?
- Possible rivaroxaban antidote identified
- Pumped about LVADs: Many eligible HF patients would "definitely" consider one
- Twice-daily aspirin yields better platelet inhibition in diabetics
- Acute-HF early-warning system implant surprises by upping HF hospitalizations
And also, in brief:
- Diuretics for acute HF can depend on specialty of treating physician
- Postprandial, but not fasting, glucose predicts CV risk in type 2 diabetes
- Apples, pears linked to reduced stroke risk
Join us for a comprehensive review of this week's most important cardiology news.
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
